Skip to main content
. 2013 Nov 12;18(11):13957–13978. doi: 10.3390/molecules181113957

Figure 5.

Cytotoxicity study of conjugate 13, compared with parent drug (PD0325901) and MEKI (11) on both melanoma A375 (A, IC50 value) and glioblastoma-U87 (B) cells after 72h treatment by the SRB method.

Figure 5

(**) indicates significant deference between conjugate 13 and parent drug PD0325901 (p value < 0.01). (##) indicates p value < 0.01.